| Properties | Information | |
|---|---|---|
| PhytoCAT-ID | PhytoCAT-813 | |
| Phytochemical name or plant extracts | Paramignya trimera extract (PTL) | |
| PMID | 28122160 | |
| Literature evidence | The findings from this study allow us to conclude that the PTL is a rich source of phytochemicals that possess promising antioxidant and anti-proliferative activities, therefore it shows potential as lead compounds for application in the nutraceutical, medicinal and pharmaceutical industries. © 2017 Wiley-VHCA AG, Zurich, Switzerland. | |
| IUPAC name | NA | |
| Phytochemicals’ class or type of plant extracts | Methanolic extract | |
| Source of phytochemicals or plant Extracts | Paramignya trimera | |
| Geographical availability | Vietnam | |
| Plant parts | Leaves | |
| Other cancers | Breast cancer, Pancreatic cancer, Colon cancer, Ovarian cancer, Lung cancer, Skin cancer, Prostate cancer, neuroblastoma, Glioma | |
| Target gene or protein | NA | |
| Gene or Protein evidence | NA | |
| Target pathways | NA | |
| IC50 | NA | |
| Potency | GI50 = 57 ± 2.1 μg/ml] | |
| Cell line/ mice model | MCF-7, MiaPaCa-2, HT29, A2780, H460, A431, Du145, BE2-C, U87, SJ-G2, and SMA | |
| Additional information | The findings from this study allow us to conclude that the PTL is a rich source of phytochemicals that possess promising antioxidant and anti-proliferative activities, therefore it shows potential as lead compounds for application in the nutraceutical, medicinal and pharmaceutical industries. | |
| PubChem ID | NA | |
| Additional PMIDs | 34472263 32496136 | |
| Additional sources of information | https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:774533-1 | |
| Safety | NA |